Transformation of follicular lymphoma

Best Pract Res Clin Haematol. 2011 Jun;24(2):147-63. doi: 10.1016/j.beha.2011.02.006. Epub 2011 May 6.

Abstract

Histological transformation of follicular lymphoma (FL) to a more aggressive non-Hodgkin's lymphomas is a pivotal event in the natural history of FL and is associated with poor outcome. While commonly observed in clinical practice and despite multiple studies designed to address its pathogenesis, the biology of this process represents an enigma. In this chapter we present a state of the art review summarizing the definition of histologic transformation, its incidence, pathogenesis, clinical manifestations, treatment and outcome. Furthermore, we specifically emphasize gaps in our knowledge that should be addressed in future studies.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / biosynthesis
  • Biopsy
  • Burkitt Lymphoma / etiology
  • Burkitt Lymphoma / genetics
  • Burkitt Lymphoma / mortality
  • Burkitt Lymphoma / pathology*
  • Burkitt Lymphoma / therapy
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / pathology*
  • Chromosome Aberrations
  • Disease Progression
  • Disease-Free Survival
  • Humans
  • Lymphoma, Follicular / complications
  • Lymphoma, Follicular / genetics
  • Lymphoma, Follicular / mortality
  • Lymphoma, Follicular / pathology*
  • Lymphoma, Follicular / therapy
  • Lymphoma, Large B-Cell, Diffuse / etiology
  • Lymphoma, Large B-Cell, Diffuse / genetics
  • Lymphoma, Large B-Cell, Diffuse / mortality
  • Lymphoma, Large B-Cell, Diffuse / pathology*
  • Lymphoma, Large B-Cell, Diffuse / therapy
  • Mutation
  • Prognosis
  • Salvage Therapy
  • Stem Cell Transplantation
  • Transplantation, Autologous

Substances

  • Biomarkers, Tumor